Keeping tabs on your menstrual cycle and then adjusting your skincare as needed can help prevent pre-period flare-ups. For ...

U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government testing found they contain slightly elevated levels of a chemical ...

Acne is a concern for teens and adults alike, with many turning to over-the-counter or prescription remedies. However, there is one acne treatment that you should immediately stop using and toss ...

This initiative aims to celebrate and empower women by providing access to non-invasive, science-backed skincare solutions that target common concerns such as aging, acne, and skin rejuvenation. What ...

The appointment is part of Pfizer's broader strategy to enhance its anti?obesity portfolio and secure a stronger global market presence.

Cystic-acne sufferers know that a cyst is not the same beast as your garden-variety pimple. While whitehead pimples sit on the surface of the skin (which, though unsightly, means they’re easier ...

If you have acne-prone skin or struggle with breakouts, you may know the benefits of retinol or pimple patches, but the one product you should never skip is a great face moisturizer. There's a ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous tariffs on imported goods, Reuters’ Christy Santhosh ...

Pfizer's CEO said he may move manufacturing back to the US in response to Donald Trump's tariffs. Albert Bourla said he was not surprised by Trump's victory in November. Trump has threatened to ...

Pfizer CEO Albert Bourla said his company is ready to shift its manufacturing operations into the U.S. should the need arise. He made the comments at the 45th TD Cowen Annual Health Care Conference in ...

Pfizer already has 13 U.S. manufacturing sites up and running, including several “megasites” for sterile injectables and antibody manufacturing, according to Bourla.

Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing ...